(Q33965083)

30 July 2017

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study (English)

1 reference

30 July 2017

0 references

1 reference

Erik Holmberg

2

0 references

Jan Adolfsson

object named as

Jan Adolfsson

series ordinal

5

0 references

Lars Holmberg

series ordinal

4

object named as

Lars Holmberg

1 reference

30 July 2017

1

Pär Stattin

1 reference

30 July 2017

6

Jonas Hugosson

1 reference

30 July 2017

Jan-Erik Johansson

3

1 reference

PubMed ID

20562373

30 July 2017

National Prostate Cancer Register (NPCR) of Sweden

series ordinal

7

1 reference

PubMed ID

20562373

30 July 2017

language of work or name

English

0 references

publication date

18 June 2010

1 reference

Journal of the National Cancer Institute

30 July 2017

1 reference

30 July 2017

102

1 reference

30 July 2017

13

1 reference

30 July 2017

950-958

1 reference

Contemporary risk profile of prostate cancer in the United States

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Screening and prostate-cancer mortality in a randomized European study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Limits of observational data in determining outcomes from cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Active surveillance for early-stage prostate cancer: review of the current literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Active surveillance for prostate cancer: for whom?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

A systematic overview of radiation therapy effects in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Active surveillance: towards a new paradigm in the management of early prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897875

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

28 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Outcomes of localized prostate cancer following conservative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Cross-national comparative performance of three versions of the ICD-10 Charlson index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Population-based study of long-term survival in patients with clinically localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Socio-economic factors and breast cancer survival – a population-based cohort study (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ154

Reliability of death certificates in prostate cancer patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20562373

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJQ154

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

20562373